Skip to main content

Table 5 Median (and interquartile range) of asthma quality of life questionnaire (AQLQ) domain scores and total score in relation to regular asthma medication and systemic corticosteroid (CS) use in pregnant women with asthma. p value from Mann–Whitney test

From: Quality of life and asthma control in pregnant women with asthma

Grouping by*

AQLQ domain

Symptoms

Activities

Emotional

Environmental stimuli

Total

Regular medication

None (n = 13)

53.6 (46.4–71.4)

67.5 (61.0–71.4)

54.3 (51.4–68.6)

75.0 (67.9–78.6)

62.9 (55.8–69.2)

 ≥ 1/day (n = 20)

56.5 (44.0–63.4)

67.5 (57.8–71.4)

57.1 (50.0–67.9)

76.8 (57.1–85.7)

63.4 (54.0–69.0)

p value

0.785

0.842

0.730

0.785

0.870

Systemic CS use

No (n = 26)

53.6 (42.9–67.3)

67.5 (60.4–70.8)

57.1 (51.4–62.9)

75.0 (66.1–82.1)

62.1 (54.0–69.0)

Yes (n = 7)

60.7 (59.5–68.5)

71.4 (59.7–74.7)

65.7 (45.7–77.1)

85.7 (60.7–85.7)

67.4 (60.3–72.5)

p value

0.241

0.277

0.549

0.410

0.307

Total

n = 33

56.0 (45.2–67.9)

67.5 (59.7–71.4)

57.1 (51.4–68.6)

75.0 (64.3–85.7)

62.9 (54.5–69.2)

  1. *For one patient medication data got lost